These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A case of sterile peritonitis associated with icodextrin solution. Reichel W; Schulze B; Dietze J; Mende W Perit Dial Int; 2001; 21(4):414-5. PubMed ID: 11587408 [No Abstract] [Full Text] [Related]
43. Sterile icodextrin-associated peritonitis may induce hypersensitivity and recurrent peritonitis on re-challenge. Enia G; Mandalari A; Ventura G; Pustorino D; Panuccio V Nephrol Dial Transplant; 2003 Mar; 18(3):626. PubMed ID: 12584300 [No Abstract] [Full Text] [Related]
44. Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Hoedemaekers CW; Klein Gunnewiek JM; Prinsen MA; Willems JL; Van der Hoeven JG Crit Care Med; 2008 Nov; 36(11):3062-6. PubMed ID: 18824915 [TBL] [Abstract][Full Text] [Related]
45. [Sterile peritonitis after administration of icodextrin]. Ekart R; Pecovnik-Balon B; Dvorsak B; Hojs R Acta Med Croatica; 2002; 56(4-5):185-7. PubMed ID: 12768899 [TBL] [Abstract][Full Text] [Related]
46. Recurrent pancreatitis in an icodextrin-based peritoneal dialysis patient. Yet another case report. Hayat A; Thaneeru P; Priest P; Wilson R N Z Med J; 2013 Jun; 126(1377):67-9. PubMed ID: 23831880 [No Abstract] [Full Text] [Related]
47. Allergic reactions to icodextrin in patients with renal failure. Divino Fiho JC Lancet; 2000 Apr; 355(9212):1364-5. PubMed ID: 10776767 [No Abstract] [Full Text] [Related]
48. Peritoneal dialysis: new developments and new problems. Gradden CW; Ahmad R; Bell GM Diabet Med; 2001 May; 18(5):360-3. PubMed ID: 11472445 [TBL] [Abstract][Full Text] [Related]
49. Successful use of icodextrin in elderly patients on continuous ambulatory peritoneal dialysis. Nakamoto H; Babazono T; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Yorioka N; Sato M; Yamabe K; Kawaguchi Y Adv Perit Dial; 2005; 21():168-74. PubMed ID: 16686312 [TBL] [Abstract][Full Text] [Related]
50. Review of clinical trial experience with icodextrin. Wolfson M; Ogrinc F; Mujais S Kidney Int Suppl; 2002 Oct; (81):S46-52. PubMed ID: 12230481 [No Abstract] [Full Text] [Related]
51. Transient sterile chemical peritonitis with icodextrin: clinical presentation, prevalence, and literature review. Tintillier M; Pochet JM; Christophe JL; Scheiff JM; Goffin E Perit Dial Int; 2002; 22(4):534-7. PubMed ID: 12322832 [No Abstract] [Full Text] [Related]
52. The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients. Gobin J; Fernando S; Santacroce S; Finkelstein FO Blood Purif; 2008; 26(3):279-83. PubMed ID: 18421212 [TBL] [Abstract][Full Text] [Related]
54. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease. Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445 [TBL] [Abstract][Full Text] [Related]